Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: ZYG24004 · Tinea Pedis Caused by Dermatophytes Primary and study completion moved earlier from Jun 10, 2027 to Mar 31, 2027
- Minor: Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study Study completion pushed from Dec 2029 to Feb 2030
- Minor: Novel Ultrasound Probe for Thyroid Imaging and Machine Learning Start date changed from estimate of Sep 1, 2026 to Sep 3, 2026
- Minor: SEMAFORCRANIO · Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years Start date pushed from Nov 2026 to Dec 2026
- Minor: SP Thoracic IDE Study Study completion pushed from Jul 2028 to Oct 2028
- Minor: Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy Interventions modified
- Minor: Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation · Advanced Head and Neck Cancer Study completion moved earlier from Feb 9, 2032 to May 28, 2031
- Minor: Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer Study completion pushed from Dec 31, 2026 to Jul 31, 2027
- Minor: Mental State of Parents of Premature Children and Impact on Neurodevelopment of the Child Study completion pushed from Aug 26, 2026 to May 26, 2027
- Minor: Leucovorin · Language Impairment in Children With Autism Spectrum Disorder Study completion pushed from Jul 31, 2026 to Jan 31, 2027
- Minor: Lemborexant on Perioperative Sleep Quality in Patients Undergoing Breast Cancer Surgery Start date pushed from Oct 16, 2026 to Nov 2026
- Minor: Letermovir for R+ Study Start date pushed from Oct 2026 to Nov 2026
- Minor: Daratumumab · Newly Diagnosed Multiple Myeloma Study completion pushed from Sep 2026 to Sep 2027
- Minor: INTERvening for LUNG Health Trial Start date pushed from Nov 15, 2026 to Dec 2, 2026
- Minor: Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients Study completion pushed from Oct 31, 2026 to Dec 25, 2026
- Minor: Brentuximab Vedotin With or Without Nivolumab · Relapsed or Refractory CD30+ Lymphoma Study completion moved earlier from Jun 3, 2030 to Aug 16, 2028
- Minor: Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI) Study completion moved earlier from Nov 8, 2028 to Jun 2027
- Minor: Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Study completion pushed from Nov 30, 2026 to May 1, 2027
- Minor: B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme Study completion pushed from Feb 2027 to Mar 2037
- Minor: CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation Study completion moved earlier from Aug 2027 to Dec 2026
- Minor: 2024 National Survey of Early Care and Education (NSECE) Longitudinal Follow-ups Study completion pushed from Mar 2026 to Mar 28, 2027
- Minor: Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort) Interventions modified
- Minor: Lower Body Negative Pressure to Validate Physiological Monitors Start date changed from estimate of Sep 30, 2026 to Nov 5, 2026
- Minor: Nerve Block Resolution Time Display and Pain Complaints Start date pushed from Oct 2026 to Nov 2026
- Minor: Sensory Neurography and S2PD, a Test-Retest Study Study completion pushed from May 2026 to Dec 31, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates